Arthritic Therapeutic Global Market Report 2024

Global Arthritic Therapeutic Market Report 2024

Arthritic Therapeutic Global Market Report 2024 – By Drug Class (Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes), By Route Of Administration (Oral, Parenteral, Topical), By Type (Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

Name: Arthritic Therapeutic Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Arthritic Therapeutic Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : November 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Global Arthritic Therapeutic Market Infographic

Proud Members Of

Arthritic Therapeutic Market Definition

Arthritic therapeutics refer to treatments designed to alleviate symptoms and improve quality of life for individuals with arthritis. This includes medications, physical therapy, and other interventions aimed at reducing pain, inflammation, and joint damage. These therapies can help manage various forms of arthritis, such as osteoarthritis and rheumatoid arthritis.

The main drug classes of arthritic therapeutic are tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, xanthine oxidase inhibitors, and others. Tumor necrosis factor (TNF) inhibitors are a class of drugs that block the action of TNF, a protein involved in inflammation, to treat autoimmune diseases They are administered through oral, parenteral, and topical routes for various types of arthritis, such as psoriatic arthritis, rheumatoid arthritis, osteoarthritis, and gout. These drugs are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

Arthritic Therapeutic Market Segmentation

The arthritic therapeutic market covered in this report is segmented –

1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Global Arthritic Therapeutic Market Size 2023 to 2028: Graph

Arthritic Therapeutic Market Size 2024 And Growth Rate

The arthritic therapeutic market size has grown strongly in recent years. It will grow from $64.19 billion in 2023 to $68.10 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increasing number of diagnosed patients, increasing awareness about the symptoms, increasing prevalence of obesity, improved diagnostic skills, and improved treatment outcomes.

Arthritic Therapeutic Market Growth Forecast

The arthritic therapeutic market size is expected to see strong growth in the next few years. It will grow to $86.55 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to improving healthcare infrastructure, government initiatives, supportive regulatory frameworks, focus on personalized medicine, and shift towards patient-centric healthcare approaches. Major trends in the forecast period include focus on biosimilar, shifting paradigm towards biologics, enhanced availability of biosimilars, preference for parenteral route, and growth of online pharmacies.

Book your 30 minutes free consultation with our research experts

Arthritic Therapeutic Market Driver: Increasing Incidence Of Arthritis Is Driving The Growth Of The Arthritic Therapeutic Market

The increasing incidence of arthritis is expected to propel the growth of the arthritic therapeutic market going forward. Arthritis refers to a group of more than 100 conditions characterized primarily by joint pain and inflammation. The incidence of arthritis is growing due to an aging population, increased obesity rates, and lifestyle factors that contribute to joint stress and inflammation. Arthritis treatments alleviate symptoms, reduce inflammation, and improve joint function, enhancing the overall quality of life for those affected. For instance, in June 2024, according to a report published by the Australian Institute of Health and Welfare, an Australia-based government organization, approximately 514,000 people (2.0% of the population) were living with rheumatoid arthritis in 2022. Rheumatoid arthritis made up 2.0% of the total disease burden and represented 16% of the total burden for all musculoskeletal conditions in 2023. Therefore, the increasing incidence of arthritis is driving the growth of the arthritic therapeutic market.

Global Arthritic Therapeutic Market Major Players

Major companies operating in the arthritic therapeutic market are Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH

Global Arthritic Therapeutic Market Trend: Innovative Biosimilar Monoclonal Antibody Therapies Enhanced Arthritis Therapeutic Market

Major companies operating in the arthritis therapeutic market are focusing on developing innovative solutions such as biosimilar monoclonal antibody-based therapies, to enhance treatment efficacy and reduce costs. Biosimilar monoclonal antibody-based therapies are treatments designed to closely replicate and mimic the effectiveness of original monoclonal antibodies, offering similar therapeutic benefits at a potentially lower cost. For instance, in May 2024, Bio-Thera Solutions Ltd., a China-based biopharmaceutical company, launched TOFIDENCE, an intravenous biosimilar monoclonal antibody formulation based on ACTEMRA. TOFIDENCE (tocilizumab-bavi) is developed to be a biosimilar to the reference drug ACTEMRA and is approved for treating moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile idiopathic arthritis.

Arthritic Therapeutic Market Merger And Acquisition: Amgen Acquired Horizon Therapeutics To Expand Rare Disease Portfolio

In October 2023, Amgen Inc., a US-based biotechnology company, acquired Horizon Therapeutics Plc for $27.8 billion. Through this acquisition, Amgen aims to enhance its portfolio of innovative medicines for rare diseases, leveraging Horizon Therapeutics' capabilities to serve more patients globally and drive long-term growth. Horizon Therapeutics plc is an Ireland-based biotechnology company that manufactures and involves arthritic therapies.

Regional Insights For The Global Arthritic Therapeutic Market

North America was the largest region in the arthritic therapeutic market in 2023. The regions covered in the arthritic therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the arthritic therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The arthritic therapeutics market consists of revenues earned by entities by providing services such as physical therapy services, occupational therapy, diagnostic services, and wellness programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The arthritic therapeutics market also includes sales of analgesics, joint injections, supplements, and disease-modifying antirheumatic drugs (DMARDs). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The arthritic therapeutic market research report is one of a series of new reports from The Business Research Company that provides arthritic therapeutic market statistics, including the arthritic therapeutic industry's global market size, regional shares, competitors with a arthritic therapeutic market share, detailed arthritic therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the arthritic therapeutic industry. This arthritic therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Arthritic Therapeutic Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2024	$ 0.75 Billion
Revenue Forecast In 2033	$ 1.59 Billion
Growth Rate	CAGR of 20.80% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes 2) By Route Of Administration: Oral, Parenteral, Topical 3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Arthritic Therapeutic Market Characteristics

3. Arthritic Therapeutic Market Trends And Strategies

4. Arthritic Therapeutic Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Arthritic Therapeutic Market Size and Growth

5.1. Global Arthritic Therapeutic Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Arthritic Therapeutic Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Arthritic Therapeutic Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Arthritic Therapeutic Market Segmentation

6.1. Global Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Tumor Necrosis Factor (TNF) Inhibitors

Interleukin Inhibitors

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Corticosteroids

Xanthine Oxidase Inhibitors

Other Drug Classes

6.2. Global Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Oral

Parenteral

Topical

6.3. Global Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Psoriatic Arthritis

Rheumatoid Arthritis

Osteoarthritis

Gout

Other Types

6.4. Global Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

7. Arthritic Therapeutic Market Regional And Country Analysis

7.1. Global Arthritic Therapeutic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Arthritic Therapeutic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Arthritic Therapeutic Market

8.1. Asia-Pacific Arthritic Therapeutic Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Arthritic Therapeutic Market

9.1. China Arthritic Therapeutic Market Overview

9.2. China Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Arthritic Therapeutic Market

10.1. India Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Arthritic Therapeutic Market

11.1. Japan Arthritic Therapeutic Market Overview

11.2. Japan Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Arthritic Therapeutic Market

12.1. Australia Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Arthritic Therapeutic Market

13.1. Indonesia Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Arthritic Therapeutic Market

14.1. South Korea Arthritic Therapeutic Market Overview

14.2. South Korea Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Arthritic Therapeutic Market

15.1. Western Europe Arthritic Therapeutic Market Overview

15.2. Western Europe Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Arthritic Therapeutic Market

16.1. UK Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Arthritic Therapeutic Market

17.1. Germany Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Arthritic Therapeutic Market

18.1. France Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Arthritic Therapeutic Market

19.1. Italy Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Arthritic Therapeutic Market

20.1. Spain Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Arthritic Therapeutic Market

21.1. Eastern Europe Arthritic Therapeutic Market Overview

21.2. Eastern Europe Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Arthritic Therapeutic Market

22.1. Russia Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Arthritic Therapeutic Market

23.1. North America Arthritic Therapeutic Market Overview

23.2. North America Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Arthritic Therapeutic Market

24.1. USA Arthritic Therapeutic Market Overview

24.2. USA Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Arthritic Therapeutic Market

25.1. Canada Arthritic Therapeutic Market Overview

25.2. Canada Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Arthritic Therapeutic Market

26.1. South America Arthritic Therapeutic Market Overview

26.2. South America Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Arthritic Therapeutic Market

27.1. Brazil Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Arthritic Therapeutic Market

28.1. Middle East Arthritic Therapeutic Market Overview

28.2. Middle East Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Arthritic Therapeutic Market

29.1. Africa Arthritic Therapeutic Market Overview

29.2. Africa Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Arthritic Therapeutic Market Competitive Landscape And Company Profiles

30.1. Arthritic Therapeutic Market Competitive Landscape

30.2. Arthritic Therapeutic Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Johnson & Johnson

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Hoffmann-La Roche Ltd

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Merck & Co Inc.

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. AbbVie Inc.

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Arthritic Therapeutic Market Other Major And Innovative Companies

31.1. Sanofi S.A.

31.2. Bristol-Myers Squibb Company

31.3. AstraZeneca Pharma AB

31.4. GlaxoSmithKline plc

31.5. Eli Lilly and Company

31.6. Amgen Inc.

31.7. Gilead Sciences Inc.

31.8. Regeneron Pharmaceuticals Inc.

31.9. Astellas Pharma Inc.

31.10. Biogen Inc.

31.11. Vertex Pharmaceuticals Incorporated

31.12. Zimmer Biomet Holdings Inc.

31.13. UCB Pharma S.A.

31.14. Incyte Corporation

31.15. Celltrion Inc.

32. Global Arthritic Therapeutic Market Competitive Benchmarking

33. Global Arthritic Therapeutic Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Arthritic Therapeutic Market

35. Arthritic Therapeutic Market Future Outlook and Potential Analysis

35.1 Arthritic Therapeutic Market In 2028 - Countries Offering Most New Opportunities

35.2 Arthritic Therapeutic Market In 2028 - Segments Offering Most New Opportunities

35.3 Arthritic Therapeutic Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Figure 1:

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Figure 3: Global Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 4: Global Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 5: Global Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 6: Global Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 7: Global Arthritic Therapeutic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 8: Global Arthritic Therapeutic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 9: Asia-Pacific, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 10: Asia-Pacific, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 11: Asia-Pacific, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 12: China, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 13: China, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 14: China, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 15: India, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 16: India, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 17: India, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 18: Japan, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 19: Japan, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 20: Japan, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 21: Australia, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 22: Australia, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 23: Australia, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 24: Indonesia, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 25: Indonesia, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 26: Indonesia, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 27: South Korea, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 28: South Korea, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 29: South Korea, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 30: Western Europe, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 31: Western Europe, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 32: Western Europe, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 33: UK, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 34: UK, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 35: UK, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 36: Germany, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 37: Germany, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 38: Germany, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 39: France, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 40: France, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 41: France, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 42: Italy, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 43: Italy, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 44: Italy, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 45: Spain, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 46: Spain, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 47: Spain, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 48: Eastern Europe, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 49: Eastern Europe, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 50: Eastern Europe, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 51: Russia, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 52: Russia, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 53: Russia, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 54: North America, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 55: North America, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 56: North America, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 57: USA, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 58: USA, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 59: USA, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 60: Canada, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 61: Canada, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 62: Canada, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 63: South America, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 64: South America, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 65: South America, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 66: Brazil, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 67: Brazil, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 68: Brazil, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 69: Middle East, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 70: Middle East, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 71: Middle East, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 72: Africa, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 73: Africa, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 74: Africa, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 75: Pfizer Inc. Financial Performance
Figure 76: Johnson & Johnson Financial Performance
Figure 77: Hoffmann-La Roche Ltd Financial Performance
Figure 78: Merck & Co Inc. Financial Performance
Figure 79: AbbVie Inc. Financial Performance

List Of Figures

Table 1:

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Arthritic Therapeutic Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 6: Global Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 7: Global Arthritic Therapeutic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 8: Global Arthritic Therapeutic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 9: Asia-Pacific, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 10: Asia-Pacific, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 11: Asia-Pacific, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 12: China, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 13: China, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 14: China, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 15: India, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 16: India, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 17: India, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 18: Japan, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 19: Japan, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 20: Japan, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 21: Australia, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 22: Australia, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 23: Australia, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 24: Indonesia, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 25: Indonesia, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 26: Indonesia, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 27: South Korea, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 28: South Korea, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 29: South Korea, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 30: Western Europe, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 31: Western Europe, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 32: Western Europe, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 33: UK, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 34: UK, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 35: UK, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 36: Germany, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 37: Germany, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 38: Germany, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 39: France, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 40: France, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 41: France, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 42: Italy, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 43: Italy, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 44: Italy, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 45: Spain, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 46: Spain, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 47: Spain, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 48: Eastern Europe, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 49: Eastern Europe, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 50: Eastern Europe, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 51: Russia, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 52: Russia, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 53: Russia, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 54: North America, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 55: North America, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 56: North America, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 57: USA, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 58: USA, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 59: USA, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 60: Canada, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 61: Canada, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 62: Canada, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 63: South America, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 64: South America, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 65: South America, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 66: Brazil, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 67: Brazil, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 68: Brazil, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 69: Middle East, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 70: Middle East, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 71: Middle East, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 72: Africa, Arthritic Therapeutic Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 73: Africa, Arthritic Therapeutic Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 74: Africa, Arthritic Therapeutic Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 75: Pfizer Inc. Financial Performance
Table 76: Johnson & Johnson Financial Performance
Table 77: Hoffmann-La Roche Ltd Financial Performance
Table 78: Merck & Co Inc. Financial Performance
Table 79: AbbVie Inc. Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

Mantle Cell Lymphoma Therapeutics Global Market Report 2024 – By Type (Combination Therapy, Monotherapy), By Mechanism of Action (Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synthesis Inhibitors, Microtubule Inhibitors, Monoclonal Antibodies, Other Mechanisms), By Route of Administration (Oral, Parenteral), By Application (Hospital, Research Institute, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Glycomic Therapeutics Global Market Report 2024 – By Class (Isolated, Synthetic), By Structures (Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures), By Mode Of Action (Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action), By Indications – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pruritus Therapeutics Global Market Report 2024 – By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products), By Route of Administration (Oral, Parenteral, Topical), By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types), By End-User (Hospitals, Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Kidney Cancer Diagnostics And Therapeutics Global Market Report 2024 – By Cancer Type (Clear Cell RCC, Papillary RCC, Chromophobe RCC, Urothelial Carcinoma And Transitional Cell Carcinoma, Other Cancer Types), By Component (Drugs, Diagnostics), By Diagnostics (Biopsy, CT Scan, Nephro-ureteroscopy, Intravenous Pyelogram, Ultrasound), By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), By End-Users (Hospitals, Pharmaceutical Labs, Genomics Laboratories) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Warts Therapeutics Global Market Report 2024 – By Type (Common Warts, Genital Warts, Flat Warts, Other Types), By Treatment (Physical Destruction, Immunomodulation, Chemical Destruction), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2024 – By Type (Branded, Generic), By Drug Class (Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class), By Distribution Channel (Hospital Pharmacy, Drug Stores, General Stores, Supermarkets), By Application (Crohn’s Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Metastatic Melanoma Therapeutics Global Market Report 2024 – By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Surgery), By Stages (Stage 0, Stage I, Stage II, Stage III, Stage IV), By End User (Hospitals, Specialty Clinics, Home Healthcare, Other End-users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gout Therapeutics Global Market Report 2024 – By Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics), By Treatment (Xanthine Oxidase Inhibitor, Uricosuria Medication), By Disease Condition (Acute, Chronic), By End-Users (Hospitals, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the arthritic therapeutic market?

How will the arthritic therapeutic market drivers and restraints affect the arthritic therapeutic market dynamics? What forces will shape the arthritic therapeutic industry going forward?

The arthritic therapeutic market major growth driver - Increasing Incidence Of Arthritis Is Driving The Growth Of The Arthritic Therapeutic Market. For further insights on the arthritic therapeutic market, request a sample here

What is the forecast market size or the forecast market value of the arthritic therapeutic market?

The arthritic therapeutic market size has grown strongly in recent years. It will grow from $64.19 billion in 2023 to $68.10 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increasing number of diagnosed patients, increasing awareness about the symptoms, increasing prevalence of obesity, improved diagnostic skills, and improved treatment outcomes. The arthritic therapeutic market size is expected to see strong growth in the next few years. It will grow to $86.55 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to improving healthcare infrastructure, government initiatives, supportive regulatory frameworks, focus on personalized medicine, and shift towards patient-centric healthcare approaches. Major trends in the forecast period include focus on biosimilar, shifting paradigm towards biologics, enhanced availability of biosimilars, preference for parenteral route, and growth of online pharmacies. For further insights on the arthritic therapeutic market, request a sample here

How is the arthritic therapeutic market segmented?

The arthritic therapeutic market is segmented
1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies For further insights on the arthritic therapeutic market, request a sample here

Which region has the largest share of the arthritic therapeutic market? What are the other regions covered in the report?

North America was the largest region in the arthritic therapeutic market in 2023. The regions covered in the arthritic therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the arthritic therapeutic market, request a sample here.

Who are the major players in the arthritic therapeutic market?

What are the key trends in the arthritic therapeutic market?

Major trend in the arthritic therapeutic market - Innovative Biosimilar Monoclonal Antibody Therapies Enhanced Arthritis Therapeutic Market. For further insights on the arthritic therapeutic market, request a sample here.

What are the major opportunities in the arthritic therapeutic market? What are the strategies for the arthritic therapeutic market?

For detailed insights on the major opportunities and strategies in the arthritic therapeutic market, request a sample here.

How does the arthritic therapeutic market relate to the overall economy and other similar markets?

For detailed insights on arthritic therapeutic market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the arthritic therapeutic industry?

For detailed insights on the mergers and acquisitions in the arthritic therapeutic industry, request a sample here.

What are the key dynamics influencing the arthritic therapeutic market growth? SWOT analysis of the arthritic therapeutic market.

For detailed insights on the key dynamics influencing the arthritic therapeutic market growth and SWOT analysis of the arthritic therapeutic industry, request a sample here.